Pamela L. Schwartzberg MD, PhD

Pamela L. Schwartzberg is a Chief of the Cell Signaling and Immunity Section at the National Institute of Allergy and Infectious Diseases. Schwartzberg received her B.A. from Princeton University and her M.D. and Ph.D. degrees from the Columbia College of Physicians and Surgeons, Columbia University. During her Ph.D. studies, she worked with Stephen Goff, Ph.D., Columbia University, on studies of retroviral replication and on early studies using homologous recombination to introduce mutations into the germline of mice — work that helped open a new era in mouse genetics. After an internship at Boston Children's Hospital, she did a fellowship with Harold Varmus, M.D., at the National Cancer Institute, working on signaling pathways involving tyrosine kinases as a special fellow of the Leukemia and Lymphoma Society (in collaboration with Michael Lenardo, M.D., National Institute of Allergy and Infectious Diseases).

She started her own laboratory at the National Human Genome Research Institute at the end of 1997 and was promoted to senior investigator with tenure in 2003. Her laboratory's work has centered on the use of genetic, biochemical, and cellular studies to understand T cell signaling, with a focus on pathways affected by primary immunodeficiencies. Dr. Schwartzberg is an adjunct faculty member at the University of Pennsylvania and the George Washington University School of Biomedical Sciences and has received several mentoring awards at NIH. She has served on numerous reviewing and editorial boards and is the recipient of a Searle Scholar's Award, the American Association of Immunologists BD-Pharmingen Biosciences Award for Early Career Scientists, and has been elected to the American Society for Clinical Investigation (ASCI), and the Association of American Physicians (AAP).